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The Evans has estab-
lished a new Section 
of Biomolecular 
Medicine to help 
strengthen the bridge 
between basic and 
clinical research. See 
page 4. 
John R. Murphy, Ph.D., head of the newly formed Biomolecular Medicine Section of the Evans, examines 
an autoradiograph of a new form of gene that he and his associates have created. 
Tracking the proteins 
that enable T-cells 
to amplify their effects 
I m m u n e responses depend to an extraordi-
nary degree on the abi l i ty of i n d i v i d u a l 
T-lymphoeytes to ampl i fy their effects. 
This is accomplished part ly by clonal ex-
pansion of i n d i v i d u a l cells: The T-cells re-
sponsive to an antigen produce lymphokines 
that s t imulate cell d ivis ion. 
Equally significant, though, is the fact that 
sensitized T-cells are able to activate other 
whi te -b lood cells. These may include not 
only macrophage-monocytes and polymorpho-
nuclear leukocytes, but also other T-cells. I n 
fact, non-sensitized T-cells are the m a i n par-
ticipants i n many T-cell-mediated inf lamma-
tory responses, according to Evans investiga-
tor D a v i d M . Center, M . D . 
" I f y o u take a typica l T-cell response to a 
transplanted kidney, for example, or poison 
ivy, y o u ' l l f i n d that only between 5 and 10 
percent of the cells involved are specifically 
sensitized to the antigens," said Dr. Center. 
"The rest were activated by lymphokines se-
creted by the sensitized cells." 
The way i n w h i c h some T-cells attract and 
temporari ly ho ld other cells, however, is 
poorly understood. These interactions are the 
m a i n research interest of Dr. Center, a mem-
ber of the Evans Pulmonary Medicine Sec-
t ion , head of the Al lergy U n i t at Univers i ty 
Hospital and an associate professor of medi-
cine at Boston Univers i ty School of M e d i -
cine. 
"We're look ing at the abi l i ty of certain T-
cell subsets to secrete various types of l y m -
phokines ," said Dr. Center, "and t ry ing to 
determine w h a t effect these lymphokines 
have on the cellular makeup of T-cell-
mediated i m m u n e responses. 
"For example," the investigator went on, 
" i t is w e l l k n o w n that the concentrations of 
T-cell subsets can vary greatly i n different 
i m m u n e responses. You can have one type of 
response w h i c h is very r i ch i n , say, helper T-
cells, and another that is enriched for sup-
pressor cells." 
Yet paradoxically, noted Dr. Center, re-
sponses to various antigens may be di f f i cu l t 
to dist inguish i n pathological terms. " I f you 
were to i m p l a n t four different kidneys i n 
Continued on page 3 
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From the Evans Director 
When the Evans was founded 
in 1912, its research staff of 10 
all worked i n the original Evans 
bui ld ing . Communication 
among its investigators must 
have been easy. Even at its 
golden anniversary i n 1962, 
research faculty had increased 
only to 20, most of them still 
housed in the (second) Evans 
bui ld ing . As a new member of the staff at 
that time, I was reasonably wel l i n touch w i t h 
what was going on at the Evans. 
However, i n parallel w i t h the rapid growth 
of Boston University Medical Center and of 
academic activities as a whole, the Evans staff 
has doubled and doubled again over the past 
two decades, to its current roster of 80 to 90. 
Over the same period, the number of trainees 
has expanded proportionately. This much 
larger staff has spread beyond the confines of 
the (third) Evans Building. Our growth , 
together w i t h the increasing specialization of 
research, has made it hard even for those 
active at the Evans to k n o w what's happening 
here. 
U n t i l now, there has been no way to keep 
the hundreds of former trainees and staff 
aware of goings-on at the Evans. This 
newsletter is an attempt to let our graduates 
and our friends k n o w about key current 
events at the Evans: new staff and areas of 
research, changes i n our training programs, 
news of ongoing activities. We hope you w i l l 
enjoy Evans Medicine, and we welcome 
feedback. 
When the Robert Dawson Evans Memorial 
Department of Clinical Research and 
Preventive Medicine—to give it its fu l l official 
name—was established i n 1912, it was one of 
the tew institutions of its k i n d . Clinical 
investigation was under way i n a number of 
other centers but separate departments of 
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clinical research were rare. The first bui lding 
embodied the key elements of Maria 
Antoinette Evans' remarkably toresighted 
vision. To quote from the description of the 
institution's first director. Dr. Frank C. 
Richardson: "The function of the bui lding is 
not confined to that of a hospital proper but 
is divided into three different services. O n the 
main floor. . . is a large lecture ha l l . . . in v hich 
popular lectures on hygiene.. .may be 
delivered. The fourth floor...contains seven 
large laboratories tor special research. In 
connection w i t h these laboratories the second 
and th i rd floors are divided into wards and 
private rooms, i n which those requiring a 
special study may be cared tor . " 
Thus, f rom the beginning the purpose of 
the Evans was laboratory research intertwined 
w i t h the clinical care of patients, w i t h the 
intent of bringing advances in medical 
knowledge to the public. The first bui lding 
was physically attached to Boston University 
School of Medicine, emphasizing the close 
relation of the Evans w i t h education and w i t h 
the School. As Boston University Medical 
Center has g r o w n , the Evans has remained a 
ful ly integrated member of the Center 
community. The Evans is not an endowment 
or a bui lding but an idea, as first defined by 
the deeds of gift f rom its donor, Mrs . Evans: 
support tor excellent clinical research, 
devotion to " t r u t h above everything" (her 
motto) i n f inding the causes of human 
diseases w i t h the ultimate goal of preventing 
them. We're still w o r k i n g to meet Mrs. Evans' 
mandate! 
Regards f rom the Evans, 
D-fviAa/vx^ 
Norman G . Levinsky, M . D . 
For Maria Antoinette 
Evans, the basic goal 
was excellent clinical 
research that would 
eventually lead to the 
prevention of 
diseases. 
'From the beginning 
the purpose of the 
Evans was laboratory 
research intertwined 
with the clinical care 
of patients...' 
The original Evans Build-
ing as it appeared early in 
its existence. The building, 
dedicated in 1912, now 
houses administrative of-
fices of Boston University 
School of Medicine. 
T-cells... 
Continued from page 1 
me," he explained, " the chances are the ma-
jor T-cell populations i n the inf lammatory 
reponse to al l four w o u l d be similar even 
though the antigens involved are obviously 
very different ." 
In exploring the mechanisms underlying T-
cell responses. Dr. Center and his associates 
began by seeking to isolate and pur i fy T-cell 
lymphokines that attract other T-cells, and 
others that i m m o b i l i z e such cells at the sites 
of inf lammations . 
The investigators were aided by the early 
discovery of ways to st imulate T-cells to pro-
duce only a handful of lymphokines, not the 
80 to ICQ typical ly produced by a cell i n re-
sponse to an antigen. 
"We ident i f ied a series of s t i m u l i that w i l l 
cause T-cells to produce only seven or eight 
lymphokines , " Dr. Center explained. "One of 
the s t i m u l i w i t h w h i c h we've had the most 
success is histamine. That raises some inter-
esting issues about the biologic l inks be-
tween immediate allergic reactions, i n w h i c h 
histamine often plays a key part, and delayed 
reactions, w h i c h often are dominated by T-
cells." 
So far, said the investigator, his group has 
purif ied one lymphokine , is close to puri fy-
ing another and is m a k i n g progress on a 
t h i r d . The l y m p h o k i n e they have purif ied is 
a chemoattractant that is produced by a 
group of cytotoxic/suppressor T-cells, and 
that targets certain helper/inducer cells. The 
other t w o lymphokines are of the type that 
immobi l izes non-sensitized T-cells. 
Through their experiments w i t h the three 
proteins, the investigators have begun to i l -
luminate various aspects of the way i n 
w h i c h sensitized T-cells enlist their non-sen-
sitized counterparts i n a response to in f lam-
mat ion . 
For one thing, said Dr. Center, i t is clear 
that the chemoattractant they have purif ied, 
LCF56 ( lymphocyte chemoattractant factor, 
molecular weight 56,000 daltons), acts at 
very l o w concentrations. 
"The concentrations are equivalent to the 
concentrations at w h i c h hormones act," said 
the investigator. "Nevertheless, the target 
cells are able to f o l l o w the concentration gra-
dient—and this usually means penetrating 
various barriers, since the target cells come 
f r o m the bloodstream or the lymphat ics . " 
The research group also has looked at how 
the i m m o b i l i z i n g lymphokines w o r k . 
"We have found that these i m m o b i l i z i n g 
lymphokines are h ighly effective at trapping 
their target T-cells," said Dr. Center, " b u t 
that they don't seem to interfere w i t h nor-
mal cell functions. The affected cells are s t i l l 
able to proliferate, and to synthesize their 
o w n proteins. 
"We also found that when we wash the 
cells away f r o m the proteins that immobi l ize 
them, the cells regain the abi l i ty to move. 
This implies that they're then available to be 
attracted to the site of another inf lamma-
t i o n . " 
Dr. Center in one of the labs involved in the T-lymphocyte research. (Photo by 
Bradford F. Herzog) 
Besides exploring the nature and functions 
of the three lymphokines , the investigators 
also have gained insight i n t o the overall 
structure of the T-cell-mediated response 
system. Even w h e n looked at solely i n terms 
of T-cel l /T-cel l interactions, the system is 
tremendously complex, suggested Dr. Center. 
In the first place, he noted, since not al l 
T-cells produce a l l lymphokines , the lympho-
kines generated i n any given response reflect 
the types of T-cells drawn to a specific anti -
gen. 
A T-cell's output of lymphokines , more-
over, depends not only on its o w n nature but 
also on the antigen involved. " I t appears that 
T-cells are preprogrammed to produce certain 
lymphokines i n response to certain antigens, 
m u c h as B-cells are preprogrammed to pro-
duce a single i m m u n o g l o b u l i n , " said Dr. 
Center. 
Considering the vast number of potential 
antigens—and the fact that the T-cell-
mediated response to an antigen depends not 
only on the protein output of the sensitized 
T-cells but also on the nature of the target T-
cells—the potential for h ighly individual ized 
responses to i n f l a m m a t i o n w o u l d seem great. 
In fact, suggested Dr. Center, the phenom-
enon of the response that is dominated by 
one T-cell subset reflects this complexity. 
" I f someone is infected by a tuberculosis 
mycobacter ium," he said, "and if the T-cells 
sensitive to the bacillus i n that person hap-
pen to produce lymphokines that target 
helper cells, then the response w i l l be domi-
nated by helper cells." 
From the standpoint of c l inical applica-
tions, of course, the T-celTmediated re-
sponses that are of most immediate concern 
are those i n w h i c h the response itself is the 
source of the pathology. The response to poi-
son i v y is one example, said Dr. Center. 
"The response to poison i v y is a specific, 
T-cell-induced response," he said. " I f you 
could ident i fy the proteins that attract T-
lymphocytes to the site exposed to the aller-
gen, you m i g h t be able to find some way of 
blocking their effects on the target cells." • 
A human T-Iymphocyte 
migrating through a nitro-
cellulose fiber. (Transmis-
sion electron micrograph 
by Charles Vacarro, M.S., 
and David Center, M.D.) 
7f appears that 
T-cells are prepro-
grammed to produce 
certain lymphokines 
in response to certain 
antigens, much as 
B-cells are prepro-
grammed to produce 
a single immuno-
globulin.' 
Biomolecular Medicine 
Section is established 
A new Section of Biomolecular Medicine has 
been established w i t h i n the Evans. 
Heading the section is John R. Murphy , 
Ph.D., w h o previously was an associate pro-
fessor of microbiology and molecular genet-
ics at Harvard Medical School and the Law-
rence J. Henderson Associate Professor of 
Heal th Sciences and Technology i n the Har-
v a r d - M I T Program i n Heal th Sciences, Tech-
nology and Management. Dr. Murphy 's re-
search interest is the potential treatment of 
disease w i t h " t a i l o r e d " molecules; for exam-
ple, he is seeking to develop model systems 
for combining altered diphtheria t o x i n and 
hormones so that the t o x i n can be specifi-
cally delivered to malignant cells. 
Besides heading the new section of the Ev-
ans, Dr. M u r p h y has been named a research 
professor of medicine and a research profes-
sor of biochemistry at BUSM. 
The a i m of the new section is to help 
bridge the gap between basic biomedical sci-
ence and the c l in ica l research that is the 
chief focus of the Evans. 
"We have excellent basic science depart-
ments w i t h i n this Medical Center, and our 
department has very productive relationships 
w i t h t h e m , " said N o r m a n G. Levinsky, 
M . D . , the Evans director. "The new section 
is i n no sense meant to be a substitute for 
those departments, but rather is meant to 
create a closer connection between basic re-
search and c l in ica l research." 
That i n t e n t i o n w i l l be reflected i n the ap-
pointments made to the new section. The 
a i m is to f i n d investigators w h o are inter-
ested i n basic science, but whose w o r k also 
has direct c l in ica l relevance. 
"We were exceptionally pleased to get Dr. 
M u r p h y , " added Dr. Levinsky. " H i s w o r k 
uses the techniques of molecular biology to 
develop approaches to therapeutic problems 
that are of the highest importance. That is 
exactly the k i n d of investigator we had i n 
m i n d w h e n we out l ined the requirements of 
this new pos i t ion . " 
Eventually, the section w i l l have four to 
five faculty-level members. Right now, the 
other faculty-level member besides Dr. M u r -
phy is James A. Burton, Ph.D., formerly of 
Massachusetts General Hospital and Harvard 
Medical School. Dr. Burton also has been 
named an associate research professor of 
medicine at BUSM. 
According to Dr. M u r p h y , the new section, 
i n addit ion to being a center of research i n 
its o w n right , w i l l help other investigators 
whose w o r k has a biomolecular dimension. 
" W h e n y o u speak of molecular biology or 
molecular genetics, what you're really talk-
ing about is a methodology," he explained. 
" T h a t methodology is broad enough to be ap-
plicable to a very wide range of biologic 
problems." 
Dr. M u r p h y noted that his section already 
has established w o r k i n g relationships w i t h 
other sections. One example, he noted, is the 
Section of Gastroenterology, headed by J. 
Thomas LaMont , M . D . 
" D r . LaMont 's group is interested i n a 
t o x i n produced by Clostridium difficile that 
causes gastrointestinal disease," said Dr. 
M u r p h y . "We're w o r k i n g together on a study 
of the molecular biology of that t o x i n . " 
As the section grows to its planned com-
plement, its range of expertise w i l l broaden. 
Dr. M u r p h y noted that his o w n background 
is strongly oriented toward recombinant 
D N A research. Dr. Burton, meanwhile , has 
specialized i n the biology and synthesis of 
peptides. 
" D r . Burton has done some very elegant 
w o r k on the nature of the peptides that spe-
cif ical ly i n h i b i t several proteases," said Dr. 
M u r p h y . " T h i s has relevance to a wide range 
of c l inical problems, f r o m preventing coloni-
zation by particular bacterial pathogens to 
hypertension." 
W h i l e i t has not yet been decided what 
other types of expertise w i l l be sought i n 
choosing addit ional staff for the new section, 
diversity w i l l be emphasized. 
Dr. M u r p h y is a native of Connecticut. He 
received his B.A. f r o m Univers i ty of Con-
necticut i n 1968 and his Ph.D. f r o m that 
university 's school of medicine i n 1972. 
The investigator's interest i n the diph-
theria t o x i n as a potential ant i - tumor agent 
dates back to early i n his research career. He 
has focused on t w o hormones as potential 
carriers for an altered version of the t o x i n : 
thyrotropin-releasing hormone (TRH) and 
melanocyte-st imulat ing hormone (MSH). 
Dr. M u r p h y and his associates already have 
carried out experiments i n w h i c h altered 
t o x i n bonded to T R H has been administered 
to rodents, w i t h encouraging results. "We 
have demonstrated that we can destroy al-
most a l l of the cells of the p i tu i ta ry that 
have T R H receptors, and spare the other 
cells of the p i t u i t a r y , " he said. 
The other model system involves creating, 
through recombinant D N A technology, a 
gene that w i l l express molecules that com-
bine the altered diphtheria t o x i n w i t h M S H . 
The first of the attempts to create and clone 
the gene, using a weakened f o r m of E. coli, 
took place this past summer at the Frederick 
Cancer Research Faci l i ty i n Frederick, M d . • 
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'When you speak of 
molecular biology or 
molecular genetics, 
what you're really 
talking about is a 
methodology... That 
methodology is broad 
enough to be applica-
ble to a very wide 
range of biologic 
problems.' 
Dr. Murphy in one of the Biomolecular Medicine 
Section labs on third floor of the Evans Building. 
(Photo by Bradford F. Herzog) 
Medicine a family affair 
for new chief resident 
For Jonathan A . Fletcher, M . D . , chief resident 
of the house staff i n the Evans Department 
of Medicine, the decision to accept a resi-
dency at Univers i ty FFospital was not a d i f f i -
cult one. 
A magna cum laude graduate of Boston 
Univers i ty School of Medicine i n the Class 
of 1981, he k n e w what to expect. "As a med-
ical student, I was impressed by Univers i ty 
Hospi ta l , " said Dr. Fletcher. " A l t h o u g h i t 's 
not a large hospital , the entire medical ser-
vice seemed to have unusual depth." 
Dr. Fletcher also anticipated—correctly, as 
i t turned out—that having some experience 
at the i n s t i t u t i o n meant he might be granted 
more responsibil i ty earlier than if he went 
elsewhere. "Once y o u k n o w people, and they 
trust y o u , " he explained, " y o u have more 
lat i tude i n terms of taking care of their pa-
t ients . " 
When he was offered the added responsi-
bil i t ies involved i n becoming chief resident 
i n medicine. Dr. Fletcher was delighted. " I 
plan to stay i n academic medicine," said the 
physician, "and this posit ion offered me an 
opportuni ty to gain further experience i n ad-
m i n i s t r a t i o n and teaching." 
The Evans' new chief resident, who stands 
a lean 6'3", entered medicine, as so many do, 
because he had role models w h o were doc-
tors. I n his case, the models were his father, 
his uncle and his grandfather. 
His father is a pathologist w h o did his resi-
dency at Boston C i t y Hospita l and is now i n 
western Massachusetts. His uncle is a hema-
tologist i n Binghamton, N.Y. His grandfather 
was a general practit ioner i n Binghamton and 
was also, said Dr. Fletcher, " the type of phy-
sician w h o had evening office hours four or 
five nights a week and worked every Satur-
day u n t i l he died at the age of 80." 
For Dr. Fletcher, therefore, the cri t ical 
choice was not so m u c h whether to enter 
medicine as what to specialize i n . The Cor-
nel l Univers i ty graduate said that he settled 
on oncology because he was drawn by the 
challenges involved i n providing effective pa-
tient care, as w e l l as the intel lectual allure of 
the field. 
"These days, there really are things that 
you can do for oncology patients, especially 
at a center l i k e t h i s , " he noted. "That applies 
both to medical therapy and to the kinds of 
psychological services that you can draw 
upon. 
"Besides that, I ' m t r u l y fascinated by can-
cer. I t generally disturbs m u l t i p l e organ sys-
tems, and that's a very challenging aspect of 
i t for me . " 
Currently, Dr. Fletcher is w o r k i n g on a re-
search project related to his area of interest. 
The research group is directed by Richard 
Bell, M . D . , a member of the Medical Oncol-
ogy Section. Its a i m is to isolate and pur i fy 
the different types of proteins expressed by 
variations of the ras oncogene. 
Speaking of the residency experience as a 
whole. Dr. Fletcher said he has not found i t 
as overwhelming as often portrayed. 
" W h e n compared to m y father's t ra ining 
25 years ago, I don't t h i n k the residency 
these days is exceptionally t r y i n g , " he said. 
" O n the other hand, for some new house 
staff the responsibilities involved i n using 
current medical technologies can cause men-
tal strains that are every b i t as tough as the 
physical strains of the long hours ." 
Whatever the rigors of the modern resi-
dency. Dr. Fletcher reported that he has had 
to put most of his outside interests on hold 
over the course of his tra ining. The major ex-
ception IS art collecting. He frequents galler-
ies i n Boston, looking for works by younger 
artists i n the region. 
" I f I had to l is t the other things I 'd l ike to 
do i f I had the t i m e , " he added, " the l ist 
w o u l d include skiing—1 grew up i n the Berk-
shire Hi l l s—sai l ing , running and reading. 
" I also play various instruments, inc luding 
the v i o l i n and piano, and I 'd love to have 
t ime to do more of tha t . " • 
Dr. Fletcher with University Hospital cancer patient Joseph Donovan of Winches-
ter, Mass. (Photo by Bradford F. Herzog) 
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'Once you know peo-
ple, and they trust 
you, you have more 
latitude in terms of 
taking care of their 
patients.' 
Noteworthy.. 
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School of Medicine and received her internal 
medicine t ra ining at Temple Universi ty . 
Jeffrey L. Hendel, M.D. , Cardiology Sec-
t ion , instructor of medicine. Dr. Hendel grad-
uated f r o m the Univers i ty of Pittsburgh 
School of Medicine and received his internal 
medicine t ra ining at Boston C i t y Hospital . 
He recently completed a cardiology fel low-
ship at Boston Univers i ty Medical Center. 
His m a i n research interest is the use of las-
ers to remove atherosclerotic plaques i n cor-
onary arteries. 
Stuart M . Levitz, M.D., Infectious Disease 
Section, instructor of medicine. Dr. Levitz 
graduated f r o m N e w York Univers i ty School 
of Medicine and trained i n internal medicine 
at Case Western Reserve Universi ty . He re-
cently completed a fel lowship i n infectious 
diseases at Univers i ty Hospital . His research 
interest is mycology, w i t h a particular focus 
on host responses to fungal infections. • 
Evans Memorial Department 
of Clinical Research 
Univers i ty Hospita l 
75 East N e w t o n Street 
Boston, M A 02118 
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Noteworthy 
The past several months have seen the ap-
pointment of a large number of new staff 
members to the Evans. Eol lowing are the 
new members, their sections and their ap-
pointments at Boston Univers i ty School of 
Medic ine : 
Vassilis I. Zannis, Ph.D., U n i t of Molecu-
lar Genetics of the Cardiovascular Inst i tute , 
associate research professor of medicine. Dr. 
Zannis former ly was an assistant professor at 
Harvard Medical School, and is an estab-
lished investigator of the Amer ican Heart 
Association. His research interests are the 
molecular bases of h u m a n disease, especially 
h u m a n inborn errors of l ipoprote in metabo-
l i s m . 
Elaine J. Alpert, M.D., General Internal 
Medicine Section, assistant professor of med-
icine. Dr. Alper t received her degree f r o m the 
Univers i ty of M i c h i g a n Medical School and 
trained i n internal medicine and rheumatol-
ogy at Boston Univers i ty Medical Center. 
Patricia Barry, M.D. , Geriatric Section, as-
sistant professor of medicine. Dr. Barry grad-
uated f r o m the Univers i ty of Southern Flor-
ida College of Medic ine and served her 
residencies at the Univers i ty of Southern 
Florida and Tampa General Hospital . Prior to 
coming to Boston Univers i ty Medical Center 
she developed a program i n geriatrics for the 
Univers i ty of Southern Florida. 
Debbie Beasley, Ph.D., Renal U n i t , assis-
tant research professor of medicine. Dr. Beas-
ley did her doctoral w o r k at the Univers i ty 
of Michigan . Her research interests center on 
renal and hypertension physiology. 
Harrison W. Farber, M.D. , Pulmonary Sec-
t ion , assistant professor of medicine. Dr. Far-
ber is a graduate of the George Washington 
Univers i ty School of Medicine and trained i n 
internal medicine at the Medical College of 
Virginia . He recently completed a pulmonary 
fel lowship at Boston Univers i ty Medical 
Center. 
Paul J. Hesketh, M.D. , Section of Medical 
Oncology, assistant professor of medicine. 
Dr. Hesketh graduated f r o m the Univers i ty 
of Connect icut School of Medicine and 
trained i n internal medicine at St. Elizabeth's 
Hospital , Boston. He recently completed a 
hematology-oncology fel lowship at Univer-
sity Hospital . His m a i n research interest is 
the granulocytic-monocytic colony st imulat -
ing factors f r o m lymphocytes. 
David A. Melnick, M.D. , Infectious Dis-
ease Section, assistant professor of medicine. 
Dr. M e l n i c k graduated f r o m Columbia Col-
lege of Physicians and Surgeons and trained 
i n internal medicine at Cornel l Medical Cen-
ter. His t ra in ing i n infectious diseases was at 
Yale Univers i ty School of Medicine. His 
m a i n research interests are host defense 
mechanisms to infec t ion and structure-
func t ion relationships i n w h i t e blood cells. 
Robert S. Moreland, Pb.D., Hypertension/ 
Atherosclerosis Section, assistant research 
professor of medicine. Dr. Moreland did his 
doctoral w o r k i n physiology at the Medical 
College of Virginia . His m a i n research inter-
est is the mechanisms involved i n vascular 
contract ion i n hypertension. 
Samuel W. Needleman, M.D. , Section of 
Medical Oncology, assistant professor of 
medicine. Dr. Needleman received his M . D . 
degree f r o m the Univers i ty of Pennsylvania 
and trained i n internal medicine at the U n i -
versity of Iowa. Most recently, he completed 
a two-year fe l lowship at the Nat iona l Cancer 
Inst i tute . His research interests center on 
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